In this issue of Blood, Roccaro and colleagues evaluate the crucial role of miRNAs in regulating the biology and prognosis of Waldenström macroglobulinemia, providing in vitro and in vivo evidences for miRNA-based targeted therapies in this disease.
CITATION STYLE
Vacca, A., & Dammacco, F. (2009). MicroRNAs to know in Waldenström macroglobulinemia. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2009-01-199828
Mendeley helps you to discover research relevant for your work.